BioSyent Inc.
BIOYF
$10.61
-$0.09-0.81%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.98% | 15.09% | 26.31% | 23.22% | 8.06% |
| Total Depreciation and Amortization | 12.93% | 115.17% | 22.70% | 68.70% | 540.00% |
| Total Amortization of Deferred Charges | -87.86% | -- | -- | -- | -76.90% |
| Total Other Non-Cash Items | -63.58% | 35.20% | 67.50% | 109.59% | 175.38% |
| Change in Net Operating Assets | 147.96% | -101.47% | 140.04% | -334.51% | 189.07% |
| Cash from Operations | 33.78% | -58.46% | 327.29% | -170.63% | 276.92% |
| Capital Expenditure | -55.56% | 200.00% | -125.00% | -504.35% | 79.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 170.70% | 108.63% | -97.37% | 260.08% | 199.11% |
| Cash from Investing | 171.79% | 108.86% | -97.63% | 257.41% | 193.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.16% | -7.39% | -5.26% | -5.56% | -5.43% |
| Issuance of Common Stock | -100.00% | -31.47% | -83.42% | -- | 142.45% |
| Repurchase of Common Stock | 99.67% | 26.32% | 93.64% | 39.37% | -361.21% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.23% | -6.93% | -6.77% | -0.98% | -5.53% |
| Other Financing Activities | 17.86% | 17.12% | 16.00% | 16.03% | 14.63% |
| Cash from Financing | 84.73% | -8.36% | 30.63% | 33.88% | -217.05% |
| Foreign Exchange rate Adjustments | -139.91% | 126.98% | -2,600.00% | -600.00% | 119.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 885.54% | 164.14% | -37.45% | -18.26% | 61.38% |